| HOME >> BIOLOGY >> TECHNOLOGY |
Total liabilities and shareholders'
equity 2,557,123 2,994,846 399,697
(1) All translations from Renminbi to US dollars as of and for the
quarter and nine months ended September 30, 2007 were made at the noon
buying rate of the Federal Reserve Bank of New York as of September
28, 2007, which was RMB 7.4928 to US$1.00
Exhibit 2
MINDRAY MEDICAL INTERNATIONAL LIMITED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three months ended September 30
2006 2007 2007
RMB RMB US$
(unaudited) (unaudited) (unaudited)
Net revenues
- PRC 172,683 287,144 38,323
- International 188,176 286,092 38,182
Net revenues 360,859 573,236 76,505
Cost of revenues (note 2) (159,758) (257,369) (34,349)
Gross profit 201,101 315,867 42,156
Selling expenses (note 2) (49,467) (83,366) (11,126)
General and administrative expenses
(note 2) (18,237) (21,195) (2,829)
Research and development expenses
(note 2) (36,497) (56,706) (7,568)
Other general expenses 23 (18) (2)
Operating income 96,923 154,582 20,631
Other income, net (1,707) 8,604 1,148
Interest income 2,336 16,755 2,236
Interest expen
'/>"/>
| SOURCE Mindray Medical International Limited Copyright©2007 PR Newswire. All rights reserved |